Advertisement
Research Article

A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

  • Jordan M. Winter,

    Affiliation: Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Laura H. Tang,

    Affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • David S. Klimstra,

    Affiliation: Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Murray F. Brennan,

    Affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Jonathan R. Brody,

    Affiliation: Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Flavio G. Rocha,

    Affiliation: Department of Surgery, Virginia Mason Medical Center, Seattle, Washington, United States of America

    X
  • Xiaoyu Jia,

    Affiliation: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Li-Xuan Qin,

    Affiliation: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Michael I. D’Angelica,

    Affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Ronald P. DeMatteo,

    Affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Yuman Fong,

    Affiliation: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • William R. Jarnagin,

    Affiliation: Department of Surgery, Virginia Mason Medical Center, Seattle, Washington, United States of America

    X
  • Eileen M. O’Reilly,

    Affiliation: Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Peter J. Allen mail

    allenp@mskcc.org

    Affiliation: Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

    X
  • Published: July 06, 2012
  • DOI: 10.1371/journal.pone.0040157

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

Correction: A Novel Survival-Based Tissue Microarray of Pancreatic Cancer Validates MUC1 and Mesothelin as Biomarkers

Jordan M. Winter, Laura H. Tang, David S. Klimstra, Murray F. Brennan, Jonathan R. Brody, Flavio G. Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I. D’Angelica, Ronald P. DeMatteo, Yuman Fong, ...
Correction | published 7 Aug 2012 | PLOS ONE
doi:10.1371/annotation/2533f354-bbec-404a-9661-2c052963b918